Treace Medical Concepts, Inc. TMCI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $207.32M-2.5% | $212.69M-2.8% | $218.88M+2.4% | $213.75M+1.4% | $210.82M+0.7% | ||
| $42.05M-2.1% | $42.94M-2.5% | $44.05M+3.7% | $42.5M+2.1% | $41.64M+1.3% | ||
| $165.27M-2.6% | $169.75M-2.9% | $174.83M+2.1% | $171.25M+1.2% | $169.18M+0.5% | ||
| 79.7%-0.1pp | 79.8%-0.1pp | 79.9%-0.2pp | 80.1%-0.1pp | 80.2%-0.1pp | ||
| $19.34M-4.6% | $20.28M-3.2% | $20.95M-1.3% | $21.23M+1.6% | $20.89M+1.5% | ||
| $138.53M-1.7% | $140.88M+0.3% | $140.49M+1.2% | $138.84M-3.2% | $143.44M-2.8% | ||
| $63.13M+0.6% | $62.74M+1.5% | $61.83M+4.7% | $59.08M+3.4% | $57.15M+2.6% | ||
| $221.01M-1.3% | $223.91M+0.3% | $223.26M+1.9% | $219.15M-1.1% | $221.48M-1.1% | ||
| $221.01M-1.3% | $223.91M+0.3% | $223.26M+1.9% | $219.15M-1.1% | $221.48M-1.1% | ||
| -$55.74M-2.9% | -$54.15M-11.8% | -$48.44M-1.1% | -$47.89M+8.4% | -$52.3M+6.1% | ||
| -26.9%-1.4pp | -25.5%-3.3pp | -22.1%+0.3pp | -22.4%+2.4pp | -24.8%+1.8pp | ||
| $5.58M+4.9% | $5.32M+0.7% | $5.28M+0.5% | $5.26M+0.2% | $5.25M-0.1% | ||
| $2.44M-12.2% | $2.78M-11.8% | $3.15M-12.1% | $3.58M-14.4% | $4.18M-14.2% | ||
| -$5.3M-9.4% | -$4.85M-190% | -$1.67M-30.0% | -$1.29M-87.3% | -$687K-1,149% | ||
| -$61.04M-3.5% | -$59M-17.7% | -$50.11M-1.9% | -$49.18M+7.2% | -$52.99M+4.9% | ||
| -29.4%-1.7pp | -27.7%-4.8pp | -22.9%+0.1pp | -23%+2.1pp | -25.1%+1.5pp | ||
| -$0.96-3.2% | -$0.93-16.3% | -$0.80-1.3% | -$0.79+7.1% | -$0.85+5.6% | ||
| -$0.96-3.2% | -$0.93-16.3% | -$0.80-1.3% | -$0.79+7.1% | -$0.85+5.6% | ||
| 254.4M+0.8% | 252.5M+0.5% | 251.3M+0.5% | 250M+0.4% | 249.1M+0.3% | ||
| 254.4M+0.8% | 252.5M+0.5% | 251.3M+0.5% | 250M+0.4% | 249.1M+0.3% | ||
| -$61.12M-3.6% | -$59.03M-17.5% | -$50.22M-2.3% | -$49.11M+7.4% | -$53M+5.0% | ||
| $2.44M-12.2% | $2.78M-11.8% | $3.15M-12.1% | $3.58M-14.4% | $4.18M-14.2% | ||
| -$5.3M-9.4% | -$4.85M-190% | -$1.67M-30.0% | -$1.29M-87.3% | -$687K-1,149% | ||
| $577K+33.6% | $432K-6.5% | $462K+18.5% | $390K+2.6% | $380K+17.3% | ||
| -$55.74M-2.9% | -$54.15M-11.8% | -$48.44M-1.1% | -$47.89M+8.4% | -$52.3M+6.1% | ||
| -$46.68M-7.2% | -$43.53M-13.4% | -$38.38M+0.2% | -$38.46M+11.2% | -$43.33M+8.3% | ||
| -$46.68M-7.2% | -$43.53M-13.4% | -$38.38M+0.2% | -$38.46M+11.2% | -$43.33M+8.3% | ||
| -22.5%-2.0pp | -20.5%-2.9pp | -17.5%+0.5pp | -18%+2.6pp | -20.6%+2.0pp | ||
| -$55.74M-2.9% | -$54.15M-11.8% | -$48.44M-1.1% | -$47.89M+8.4% | -$52.3M+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Treace Medical Concepts, Inc.'s revenue?
- Treace Medical Concepts, Inc. (TMCI) generated $207.3M in revenue over the trailing twelve months, down 1.7% year over year.
- Is Treace Medical Concepts, Inc. profitable?
- Treace Medical Concepts, Inc. is not currently profitable: it reported a net loss of $61.0M over the trailing twelve months, a -29.4% net margin.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Gross margin is 79.7% and operating margin is -26.9%, with a -29.4% net margin.
- What is Treace Medical Concepts, Inc.'s earnings per share?
- Treace Medical Concepts, Inc.'s diluted EPS over the trailing twelve months is $-0.96.
- Where does Treace Medical Concepts, Inc.'s income statement data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
